Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06173440
Status:
RECRUITING
Last Update Posted:
2023-12-15
First Post:
2022-11-07
Brief Title:
Management of an Imipenem-resistant Acinetobacter Baumannii Alert in a French University Hospital
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
Management of an Imipenem-resistant Acinetobacter Baumannii Alert in a French University Hospital A Retrospective Study
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Baumannii
Brief Summary:
Colonization with imipenem-resistant Acinetobacter baumannii IBA is an unfavorable event for the patient especially in intensive care Indeed it exposes the patient to the risk of developing serious infections extremely difficult to treat ABRI is a particularly resistant bacterium in the environment When an ABRI epidemic occurs in a department as central to the hospital as a surgical resuscitation department the control of such an event can be extremely complex There are few clear and detailed descriptions in the literature of how to manage this type of outbreak let alone an ABRI outbreak of this magnitude
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None